Skip to Main Content

Faculty Directory

Back to
Faculty Directory

Meghan Heberton, M.D.

Titles and Appointments

Assistant Professor

School
Medical School
Department
Dermatology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Education
    Medical School
    McGovern Medical School at the University of Texas Health Science Center at Houston (2013)
    Residency
    Washington University Barnes Jewish Hospital/ St. Louis Children's Hospital Consortium Program (2016), Internal Medicine
    Residency
    Washington University in St. Louis School of Medicine (2019), Dermatology
  • Publications

    Star Featured Publications

    Imatinib associated discoid lupus erythematosus in a patient with chronic myeloid leukemia.
    Sarlashkar P, Carr C, Heberton M, JAAD Case Rep 2024 Nov 53 60-62
    Erythema multiforme-like targetoid eruption in two patients treated with capivasertib for metastatic breast cancer.
    Keum H, Zhu JL, Heberton M, Vandergriff T, Dominguez AR, JAAD Case Rep 2024 Nov 53 79-82
    Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency.
    Ying W, Long X, Vandergriff T, Karnati H, Heberton M, Chen M, Wang X, Wysocki C, Kong XF, J Clin Immunol 2024 Aug 44 8 172
    Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: A single-center cohort study.
    Sarlashkar P, Gill JG, Heberton M, J Am Acad Dermatol 2024 Jul
    Increased presentation for vitiligo cutaneous immune related adverse events in Hispanic patients.
    Momin ZK, Gill JG, Heberton M, Arch Dermatol Res 2024 May 316 6 293
    Tumoral melanosis: A case series of patients with metastatic melanoma after systemic immunotherapy.
    Wix SN, Heberton M, Vandergriff TW, Yancey KB, Gill JG, JAAD Case Rep 2024 Mar 45 82-87
    Clinical Features and Outcomes of Black Patients with Melanoma.
    Wix SN, Brown AB, Heberton M, Adamson AS, Gill JG, JAMA Dermatol 2024 Jan
    Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
    Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC, J Cutan Pathol 2023 Mar
    Durvalumab-associated generalized morphea with overlapping vitiligo.
    Martel J, Cho WC, Runge JS, Patel AB, Tayar J, Woodman K, Hume CB, Curry J, Heberton M, JAAD Case Rep 2022 Dec 30 83-86
    A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes.
    Bur D, Patel AB, Nelson K, Huen A, Pacha O, Phillips R, Heberton M, J Am Acad Dermatol 2022 Dec 87 6 1394-1395